Opsidio LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.opsidio.com
Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis
Phase 2
Active, not recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- Biological: OpSCFBiological: PlaceboBiological: OpSCF (Open Label Extension)
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Opsidio, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06101823
- Locations
- 🇺🇸
Axon Clinical Research, Inglewood, California, United States
🇺🇸Unison Clinical Trials, Sherman Oaks, California, United States
🇺🇸Options Research Group, West Lafayette, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath